Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

Eicosapentaenoic acid (EPA) is a triglyceride-lowering agent that reduces circulating levels of the apolipoprotein B (apoB)-containing lipoprotein particles small dense low-density lipoprotein (sdLDL), very–low-density lipoprotein (VLDL), and oxidized low-density lipoprotein (LDL). These benefits ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, R. Preston, Sherratt, Samuel C.R., Jacob, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936437/
https://www.ncbi.nlm.nih.gov/pubmed/26945158
http://dx.doi.org/10.1097/FJC.0000000000000379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936437/
https://www.ncbi.nlm.nih.gov/pubmed/26945158
http://dx.doi.org/10.1097/FJC.0000000000000379

Ejemplares similares